Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab Treatment in Patients With Chronic Kidney Disease (CKD) at High Risk of Fracture: A Prospective, Randomised Controlled Study

NCT05692297 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT05692297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab Treatment in Patients With Chronic Kidney Disease (CKD) at High Risk of Fracture: A Prospective, Randomised Controlled Study
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 31, 2025
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone density, low, chronic kidney diseases, end stage renal disease, fracture